BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2020

View Archived Issues

BeyondSpring submits patent application for BPI-002 as antiviral treatment

Read More

Virometix receives approval to initiate phase I study of V-306

Read More

Phase I results for vesatolimod in HIV controllers

Read More

First-in-human data for AAV8-coRPGR gene therapy

Read More

New mouse model of Charcot arthropathy

Read More

GARDP and Daiichi Sankyo partner for the discovery of new antibiotics

Read More

Medicago announces advances in the production of vaccine candidate for COVID-19

Read More

PLX cells to be developed for the potential treatment of complications caused by COVID-19

Read More

Positive results presented from phase Ib portion of PREVAIL study of PRV-3279

Read More

5-Hydroxymethylcytosine is a marker in classical Hodgkin's lymphoma

Read More

AbbVie receives EC approval of Venclyxto plus obinutuzumab for adults with CLL

Read More

Obschestvo S Ogranichennoi Otvetstvennostiyu "Z Therapeutics" divulges GC inhibitors

Read More

Roche patents Toll-like receptor antagonists

Read More

Mirati Therapeutics and Array BioPharma identify KRAS mutant inhibitors

Read More

Arcus Biosciences presents new CD73 inhibitors

Read More

Phase II data reported for RP-101 in moderate-to-severe DED

Read More

New mouse model with reduced editing in AMPA receptor GluA2(Q) site to study CNS disorders

Read More

Cytokinetics describes new cardiac myosin inhibitors

Read More

KIF15, MAD1L1 and DEPTOR expression are associated with susceptibility to IPF, large GWAS shows

Read More

First patient dosed in phase II study of HLX-10 plus chemotherapy in advanced cervical cancer

Read More

AbCellera and Eli Lilly establish collaboration to codevelop antibody products for COVID-19

Read More

Dual PMIX/PMX inhibitor WM-382 clears malaria parasites in vivo

Read More

CROI 2020: For beating HIV, how good is best?

Read More

Emergent BioSolutions begins development of hyperimmune-based candidates for COVID-19

Read More

Chinese trial studies utility of ASC-09F for COVID-19 pneumonia

Read More

ART-24 begins phase I trial for prevention of recurrence of C. difficile infection

Read More

FDA approves Opdivo plus Yervoy for the treatment of HCC previously treated with sorafenib

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • Brain and DNA

    XPC-837 restores network dysfunction in Dravet syndrome models

    BioWorld Science
    Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing